Q4 FY2021 is expected to continue to be affected by restrictions related to the pandemic with $6.0m in backlog and
anticipated orders for the Technology Division, delayed until FY2022. This includes high margin revenue from the
IMoD contract and Aura IQ which will adversely affect FY2021 EBITDA but is expected to contribute in FY2022.
Pretty great news imo, pcp revenue growth and not accounting for 6m of backlogged orders.
Q4 FY2021 is expected to continue to be affected by restrictions...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $30.4M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 10.5¢ | $42.38K | 371.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 309737 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 43343 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVA (ASX) Chart |